Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

28.6%

2 terminated out of 7 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
Early P 1 (1)
P 4 (1)

Trial Status

Terminated2
Completed2
Active Not Recruiting1
Not Yet Recruiting1
Unknown1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (7)

Research Network

Activity Timeline